Etrolizumab versus infliximab in the treatment of induction phase of ulcerative colitis: A systematic review and indirect comparison.
Motaghi, Ehsan
Etrolizumab versus infliximab in the treatment of induction phase of ulcerative colitis: A systematic review and indirect comparison. [electronic resource] - Pharmacological research 01 2019 - 120-125 p. digital
Publication Type: Comparative Study; Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't; Systematic Review
1096-1186
10.1016/j.phrs.2018.11.003 doi
Antibodies, Monoclonal, Humanized--therapeutic use
Colitis, Ulcerative--drug therapy
Gastrointestinal Agents--therapeutic use
Humans
Infliximab--therapeutic use
Etrolizumab versus infliximab in the treatment of induction phase of ulcerative colitis: A systematic review and indirect comparison. [electronic resource] - Pharmacological research 01 2019 - 120-125 p. digital
Publication Type: Comparative Study; Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't; Systematic Review
1096-1186
10.1016/j.phrs.2018.11.003 doi
Antibodies, Monoclonal, Humanized--therapeutic use
Colitis, Ulcerative--drug therapy
Gastrointestinal Agents--therapeutic use
Humans
Infliximab--therapeutic use